AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ProKidney Corp. Class A Ordinary Shares
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG0119BQ3S7
1.41▼ 0.02 (-1.40%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.43
Day's Range
1.37 – 1.44
52-Week Range
1.30 – 3.48
Volume
534.2K
Avg Volume
1.4M
Share Statistics
Shares Outstanding
Employees
231
Exchange
XNAS
Listed
2022-07-12
Share count as of August 10, 2026

ProKidney Corp. Class A Ordinary Shares (PROK) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about ProKidney Corp. Class A Ordinary Shares (PROK)
What is ProKidney Corp. Class A Ordinary Shares's Market Cap?
ProKidney Corp. Class A Ordinary Shares's Market Cap is $426.3M, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's Enterprise Value?
ProKidney Corp. Class A Ordinary Shares's Enterprise Value is $351.5M, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's Price / Sales?
ProKidney Corp. Class A Ordinary Shares's Price / Sales is 521.1×, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's EV / Revenue?
ProKidney Corp. Class A Ordinary Shares's EV / Revenue is 429.7×, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's EV / EBITDA?
ProKidney Corp. Class A Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's Revenue (TTM)?
ProKidney Corp. Class A Ordinary Shares's Revenue (TTM) is $818.0K, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's Net Income (TTM)?
ProKidney Corp. Class A Ordinary Shares's Net Income (TTM) is -$84.2M, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's EBITDA?
ProKidney Corp. Class A Ordinary Shares's EBITDA is -$170.4M, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's Diluted EPS (TTM)?
ProKidney Corp. Class A Ordinary Shares's Diluted EPS (TTM) is -0.28, based on as-reported figures from SEC (XBRL) filings.
What is ProKidney Corp. Class A Ordinary Shares's EBITDA Margin?
ProKidney Corp. Class A Ordinary Shares's EBITDA Margin is -20827.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PROKAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-34.8%+196.1%—
Operating expenses
Research and development
General and administrative
Total operating expenses
% of revenue32348.7%20264.9%17859.9%
Operating loss
% of revenue-32248.7%-20164.9%-17759.9%
Interest income
Interest expense
Net loss before income taxes
Net loss before noncontrolling interest
% of revenue-30957.3%-18156.4%-16517.5%
Net loss attributable to noncontrolling interest
Net loss available to Class A common stockholders
% of revenue-18948.0%-8547.1%-7589.4%
Net loss per share attributable to Class A common stock, Basic
Net loss per share attributable to Class A common stock, Diluted